Story thread · 2 reports / 2 sources
Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System
thestar.com · 2h · first report
MISSISSAUGA, Ontario, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Traferox Technologies, Inc. today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the X°Port® Heart Preservation System, a device that enables static 10°C heart preservation during…
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.